Libertino J, Ahmed M, Piemonte T, Gee J
Cancers (Basel). 2025; 17(2).
PMID: 39858046
PMC: 11763624.
DOI: 10.3390/cancers17020264.
Goswamy R, Kalemoglu E, Master V, Bilen M
Front Oncol. 2024; 14:1362172.
PMID: 38841158
PMC: 11151741.
DOI: 10.3389/fonc.2024.1362172.
Zhu B, Yang Y, Huangfu Z, Zhang W, Jiang A, Wang L
Transl Androl Urol. 2023; 12(11):1645-1657.
PMID: 38106682
PMC: 10719766.
DOI: 10.21037/tau-23-341.
Tabbara M, Gonzalez J, Ciancio G
Ann Transl Med. 2023; 11(6):262.
PMID: 37082681
PMC: 10113093.
DOI: 10.21037/atm-22-2877.
Tabbara M, Gonzalez J, Ciancio G
Med Res Arch. 2023; 10(7).
PMID: 36714035
PMC: 9879345.
DOI: 10.18103/mra.v10i7.2913.
Current Approaches in Surgical and Immunotherapy-Based Management of Renal Cell Carcinoma with Tumor Thrombus.
Tabbara M, Gonzalez J, Martucci M, Ciancio G
Biomedicines. 2023; 11(1).
PMID: 36672712
PMC: 9855836.
DOI: 10.3390/biomedicines11010204.
Complementary roles of surgery and systemic treatment in clear cell renal cell carcinoma.
Ingels A, Campi R, Capitanio U, Amparore D, Bertolo R, Carbonara U
Nat Rev Urol. 2022; 19(7):391-418.
PMID: 35546184
DOI: 10.1038/s41585-022-00592-3.
A case of clear cell renal cell carcinoma with vena cava thrombus responding to presurgical avelumab, and axitinib.
Suzuki I, Kijima T, Takada-Owada A, Nakamura G, Uematsu T, Sakamoto K
IJU Case Rep. 2021; 4(6):412-416.
PMID: 34755071
PMC: 8560442.
DOI: 10.1002/iju5.12362.
Roles of microRNA-186 and vascular endothelial growth factor in hepatocellular carcinoma complicated with portal vein tumor thrombus.
Yuan W, Li F
Exp Ther Med. 2020; 20(4):3860-3867.
PMID: 32855736
PMC: 7444326.
DOI: 10.3892/etm.2020.9092.
Sunitinib cause delayed complete response on metastatic RCC and extensive IVC thrombus, but not to the kidney tumor: a case report and review of literature.
Beltagy A, Ismail A, Elmansy H, Shahrour W, Prowse O, Kotb A
J Surg Case Rep. 2019; 2019(11):rjz326.
PMID: 31737248
PMC: 6847936.
DOI: 10.1093/jscr/rjz326.
Remarkable effect of presurgical nivolumab on originally inoperable papillary renal cell carcinoma with tumor thrombus in inferior vena cava.
Shinagawa T, Ito H, Sakai Y, Mikami S, Oe H, Taga M
Int Cancer Conf J. 2019; 8(4):170-174.
PMID: 31559117
PMC: 6744542.
DOI: 10.1007/s13691-019-00379-1.
Long-term survival and prognostic factors for locally advanced renal cell carcinoma with renal vein tumor thrombus.
Cao C, Bi X, Liang J, Li L, Zhang H, Xiao Z
BMC Cancer. 2019; 19(1):144.
PMID: 30760245
PMC: 6373083.
DOI: 10.1186/s12885-019-5359-0.
Expression and role of VEGFA and miR-381 in portal vein tumor thrombi in patients with hepatocellular carcinoma.
Wang J, Wu S, Huang T
Exp Ther Med. 2018; 15(6):5450-5456.
PMID: 29904424
PMC: 5996705.
DOI: 10.3892/etm.2018.6129.
Role of presurgical targeted molecular therapy in renal cell carcinoma with an inferior vena cava tumor thrombus.
Peng C, Gu L, Wang L, Huang Q, Wang B, Guo G
Onco Targets Ther. 2018; 11:1997-2005.
PMID: 29670375
PMC: 5898583.
DOI: 10.2147/OTT.S158114.
Tumor thrombus: incidence, imaging, prognosis and treatment.
Quencer K, Friedman T, Sheth R, Oklu R
Cardiovasc Diagn Ther. 2018; 7(Suppl 3):S165-S177.
PMID: 29399520
PMC: 5778532.
DOI: 10.21037/cdt.2017.09.16.
Limited benefit of targeted molecular therapy for inferior vena cava thrombus associated with renal cell carcinoma.
Fukuda H, Kondo T, Takagi T, Iizuka J, Nagashima Y, Tanabe K
Int J Clin Oncol. 2017; 22(4):767-773.
PMID: 28365808
DOI: 10.1007/s10147-017-1119-9.
[Level IV inferior vena cava tumor thrombus : A rare diagnosis in patients with renal cell carcinoma].
Hofer L, Gasch C, Hatiboglu G, Motsch J, Grullich C, Duensing S
Urologe A. 2017; 56(7):868-875.
PMID: 28349189
DOI: 10.1007/s00120-017-0369-5.
The enduring patency of primary inferior vena cava repair.
Mansukhani N, Havelka G, Helenowski I, Rodriguez H, Hoel A, Eskandari M
Surgery. 2016; 161(5):1414-1422.
PMID: 28011005
PMC: 5404996.
DOI: 10.1016/j.surg.2016.11.006.
Clinical and histopathological effects of presurgical treatment with sunitinib for renal cell carcinoma with inferior vena cava tumor thrombus at a single institution.
Ujike T, Uemura M, Kawashima A, Nagahara A, Fujita K, Miyagawa Y
Anticancer Drugs. 2016; 27(10):1038-43.
PMID: 27557138
PMC: 5049971.
DOI: 10.1097/CAD.0000000000000422.
Multi-disciplinary surgical approach to the management of patients with renal cell carcinoma with venous tumor thrombus: 15 year experience and lessons learned.
Gayed B, Youssef R, Darwish O, Kapur P, Bagrodia A, Brugarolas J
BMC Urol. 2016; 16(1):43.
PMID: 27435269
PMC: 4952069.
DOI: 10.1186/s12894-016-0157-3.